Literature DB >> 33562269

Diagnostic and Prognostic Characteristics of Circulating Free DNA Methylation Detected by the Electrochemical Method in Malignant Tumors.

Li-Yue Sun1,2,3, Zi-Ming Du1,2,3, Yu-Ying Liu1,2,4, Yan-Hong Li1,2,4, Xiao-Min Liu1,2,5, Ting Wang1,2,3, Jian-Yong Shao1,2,3.   

Abstract

Prior research has established an electrochemical method based on the differential adsorption capacity of gold surfaces with different methylated DNA degrees and found that this method might be valuable for cancer diagnosis by detecting circulating free DNA methylation. However, further investigation on the underlying mechanism and validation of its diagnostic and prognostic values in a large cohort of malignant tumors was limited. We found that DNA with different methylation levels formed particles of diverse sizes on the gold surface. Hydrophobic bonds played a significant role in the binding process of methylated DNA to the gold surface. The detection condition of an adsorption time of 10 min and temperature of 20 °C was optimal. In a large cohort of plasma samples from the patients with different malignant tumors, as well as normal individuals, we found that the electrochemical detection method based on the differential adsorption capacity of methylated DNA degree on a gold surface could be used as a noninvasive tool for malignant tumor diagnosis and prognostic evaluation. The diagnostic efficiency of this method in malignant tumors was even slightly better than that of the current tumor biomarkers widely used in routine clinical practice (circulating free DNA (cfDNA) vs. carcinoembryonic antigen (CEA), 0.8131 vs. 0.7191 and cfDNA vs. CA19-9, 0.7687 vs. 0.6693).

Entities:  

Keywords:  circulating free DNA methylation; diagnostic; electrochemical; malignant tumor; prognostic

Year:  2021        PMID: 33562269      PMCID: PMC7914975          DOI: 10.3390/cancers13040664

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  40 in total

1.  Kinetics and mechanism of single-stranded DNA adsorption onto citrate-stabilized gold nanoparticles in colloidal solution.

Authors:  Edward M Nelson; Lewis J Rothberg
Journal:  Langmuir       Date:  2011-01-10       Impact factor: 3.882

2.  Global strategies for cervical cancer control in the 21st century.

Authors:  Ted Trimble
Journal:  Gynecol Oncol       Date:  2005-12       Impact factor: 5.482

3.  Simple and sensitive aptamer-based colorimetric sensing of protein using unmodified gold nanoparticle probes.

Authors:  Hui Wei; Bingling Li; Jing Li; Erkang Wang; Shaojun Dong
Journal:  Chem Commun (Camb)       Date:  2007-06-29       Impact factor: 6.222

4.  Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials.

Authors:  James Chih-Hsin Yang; Yi-Long Wu; Martin Schuler; Martin Sebastian; Sanjay Popat; Nobuyuki Yamamoto; Caicun Zhou; Cheng-Ping Hu; Kenneth O'Byrne; Jifeng Feng; Shun Lu; Yunchao Huang; Sarayut L Geater; Kye Young Lee; Chun-Ming Tsai; Vera Gorbunova; Vera Hirsh; Jaafar Bennouna; Sergey Orlov; Tony Mok; Michael Boyer; Wu-Chou Su; Ki Hyeong Lee; Terufumi Kato; Dan Massey; Mehdi Shahidi; Victoria Zazulina; Lecia V Sequist
Journal:  Lancet Oncol       Date:  2015-01-12       Impact factor: 41.316

Review 5.  Strategies for global control of cervical cancer.

Authors:  J Pontén; H O Adami; R Bergström; J Dillner; L G Friberg; L Gustafsson; A B Miller; D M Parkin; P Sparén; D Trichopoulos
Journal:  Int J Cancer       Date:  1995-01-03       Impact factor: 7.396

6.  Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.

Authors:  Rui-Hua Xu; Wei Wei; Michal Krawczyk; Wenqiu Wang; Huiyan Luo; Ken Flagg; Shaohua Yi; William Shi; Qingli Quan; Kang Li; Lianghong Zheng; Heng Zhang; Bennett A Caughey; Qi Zhao; Jiayi Hou; Runze Zhang; Yanxin Xu; Huimin Cai; Gen Li; Rui Hou; Zheng Zhong; Danni Lin; Xin Fu; Jie Zhu; Yaou Duan; Meixing Yu; Binwu Ying; Wengeng Zhang; Juan Wang; Edward Zhang; Charlotte Zhang; Oulan Li; Rongping Guo; Hannah Carter; Jian-Kang Zhu; Xiaoke Hao; Kang Zhang
Journal:  Nat Mater       Date:  2017-10-09       Impact factor: 43.841

Review 7.  Newer markers for hepatocellular carcinoma.

Authors:  Jorge A Marrero; Anna S F Lok
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 8.  The diagnostic accuracy of carcinoembryonic antigen to detect colorectal cancer recurrence - A systematic review.

Authors:  Caspar G Sørensen; William K Karlsson; Hans-Christian Pommergaard; Jakob Burcharth; Jacob Rosenberg
Journal:  Int J Surg       Date:  2015-12-15       Impact factor: 6.071

Review 9.  Technical progress in circulating tumor DNA analysis using next generation sequencing.

Authors:  Yunfei Bai; Zexin Wang; Zhiyu Liu; Geyu Liang; Wanjun Gu; Qinyu Ge
Journal:  Mol Cell Probes       Date:  2019-11-08       Impact factor: 2.365

10.  Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker.

Authors:  Abu Ali Ibn Sina; Laura G Carrascosa; Ziyu Liang; Yadveer S Grewal; Andri Wardiana; Muhammad J A Shiddiky; Robert A Gardiner; Hemamali Samaratunga; Maher K Gandhi; Rodney J Scott; Darren Korbie; Matt Trau
Journal:  Nat Commun       Date:  2018-12-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.